| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... Nature medicine 27 (7), 1205-1211, 2021 | 3596 | 2021 |
| A serological assay to detect SARS-CoV-2 seroconversion in humans F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ... Nature medicine 26 (7), 1033-1036, 2020 | 2030 | 2020 |
| Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 I Thevarajan, THO Nguyen, M Koutsakos, J Druce, L Caly, ... Nature medicine 26 (4), 453-455, 2020 | 1263 | 2020 |
| Quantifiable predictive features define epitope-specific T cell receptor repertoires P Dash, AJ Fiore-Gartland, T Hertz, GC Wang, S Sharma, A Souquette, ... Nature 547 (7661), 89-93, 2017 | 761 | 2017 |
| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 718 | 2022 |
| Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies WS Lee, AK Wheatley, SJ Kent, BJ DeKosky Nature microbiology 5 (10), 1185-1191, 2020 | 718 | 2020 |
| Evolution and transmission of stable CTL escape mutations in HIV infection PJR Goulder, C Brander, Y Tang, C Tremblay, RA Colbert, MM Addo, ... Nature 412 (6844), 334-338, 2001 | 702 | 2001 |
| Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation LK Mackay, AT Stock, JZ Ma, CM Jones, SJ Kent, SN Mueller, WR Heath, ... Proceedings of the National Academy of Sciences 109 (18), 7037-7042, 2012 | 668 | 2012 |
| Minimum information reporting in bio–nano experimental literature M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ... Nature nanotechnology 13 (9), 777-785, 2018 | 539 | 2018 |
| Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... The Lancet Microbe 3 (1), e52-e61, 2022 | 502 | 2022 |
| Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 JA Juno, HX Tan, WS Lee, A Reynaldi, HG Kelly, K Wragg, R Esterbauer, ... Nature medicine 26 (9), 1428-1434, 2020 | 449 | 2020 |
| Antibody landscapes after influenza virus infection or vaccination JM Fonville, SH Wilks, SL James, A Fox, M Ventresca, M Aban, L Xue, ... Science 346 (6212), 996-1000, 2014 | 449 | 2014 |
| Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with … SJ Kent, A Zhao, SJ Best, JD Chandler, DB Boyle, IA Ramshaw Journal of virology 72 (12), 10180-10188, 1998 | 419 | 1998 |
| Tuberculous meningitis: a 30-year review SJ Kent, SM Crowe, A Yung, CR Lucas, AM Mijch Clinical infectious diseases 17 (6), 987-994, 1993 | 383 | 1993 |
| Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 360 | 2021 |
| Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells M Rigau, S Ostrouska, TS Fulford, DN Johnson, K Woods, Z Ruan, ... Science 367 (6478), eaay5516, 2020 | 339 | 2020 |
| Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection PJR Goulder, MA Altfeld, ES Rosenberg, T Nguyen, Y Tang, RL Eldridge, ... The Journal of experimental medicine 193 (2), 181-194, 2001 | 335 | 2001 |
| Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016 | 306 | 2016 |
| Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection D Cromer, JA Juno, D Khoury, A Reynaldi, AK Wheatley, SJ Kent, ... Nature Reviews Immunology 21 (6), 395-404, 2021 | 269 | 2021 |
| A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 24 (4), 408-416, 2018 | 255 | 2018 |
